Gayatri Bioorganics Limited Schedules Board Meeting on May 19, 2026 to Approve Audited FY26 Financial Results
Gayatri Bioorganics Limited has notified BSE Limited of a Board of Directors meeting to be held on May 19, 2026, at its registered office in Hyderabad. The meeting's primary agenda is to consider and approve the audited financial results and audit report for the quarter and year ended March 31, 2026. The intimation, filed under Regulation 33, was submitted on May 12, 2026, and digitally signed by Whole-time Director Sreedhara Reddy Kanaparthy.

*this image is generated using AI for illustrative purposes only.
Gayatri Bioorganics Limited has informed BSE Limited of a forthcoming Board of Directors meeting scheduled for Tuesday, May 19, 2026. The meeting will be held at the company's registered office located at B3, 3rd Floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad – 500082, Telangana.
Board Meeting Agenda
The board meeting has been convened to address the following key items:
- Audited Financial Results: To consider and approve the audited financial results of the company along with the audit report for the quarter and year ended March 31, 2026.
- Other Business: Any other business with the permission of the Chair.
Meeting Details at a Glance
The following table summarises the key details of the scheduled board meeting:
| Parameter: | Details |
|---|---|
| Meeting Date: | Tuesday, May 19, 2026 |
| Intimation Date: | May 12, 2026 |
| Venue: | B3, 3rd Floor, 6-3-1090, TSR Towers, Raj Bhavan Road, Somajiguda, Hyderabad – 500082, Telangana |
| Agenda: | Audited financial results for quarter and year ended March 31, 2026 |
| Signatory: | Sreedhara Reddy Kanaparthy, Whole-time Director |
Regulatory Intimation
The intimation was submitted to BSE Limited in compliance with Regulation 33 of the applicable listing obligations. The communication was digitally signed by Sreedhara Reddy Kanaparthy, Whole-time Director (DIN: 09608890), on May 12, 2026.
Historical Stock Returns for Gayatri Bioorganics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -22.00% | -13.64% | +23.40% | +116.35% | +128.35% |
How have Gayatri Bioorganics' revenue and profitability trends evolved over the past few fiscal years, and what growth trajectory might the FY2026 annual results reveal?
Will the board consider declaring a dividend for FY2026 alongside the financial results, given the company's cash flow position and capital allocation strategy?
How is Gayatri Bioorganics positioned competitively in the bioorganics sector, and could the FY2026 results signal any strategic expansion or diversification plans?































